New cancer clinical trial: 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Published on: January 15, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share